Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT05661760
Other study ID # CIR-001
Secondary ID 41150323011N
Status Active, not recruiting
Phase
First received
Last updated
Start date January 1, 2019
Est. completion date December 31, 2023

Study information

Verified date November 2022
Source Maastricht University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The goal of this prospective study is to identify variables that can predict whether an interdisciplinary biopsychosocial intervention for patients with osteoarthritis will be successful. Using an observational design, patients admitted to this program during the 3-year period (2019-2021) will be included and data gathered during routine clinical practice at baseline and end of treatment of patients who gave informed consent, will be used. With these data a prediction model will be build and internal validation with bootstrapping will be done.


Description:

Rationale: To predict the probability of a positive outcome of interdisciplinary biopsychosocial intervention in individual patients with osteoarthritis (OA), a prediction model is needed. Research Question/Objective: The overall goal is to develop a clinical prediction model to facilitate decision making in interdisciplinary biopsychosocial rehabilitation in patients with OA. The model will predict the individual probability (in percentage) of a positive response to the treatment (treatment success). Design: A retrospective cohort design. Setting: A Dutch rehabilitation facility. Participants: Patients with OA diagnosed by a medical specialist and consisting at least three months. Intervention and procedures: The intervention of interest is interdisciplinary biopsychosocial rehabilitation. The procedures include the development of a clinical prediction model and assessment of its performance and internal validity. Measurements: Candidate predictors will be carefully selected. The outcome of the model will be treatment success, defined by the change on the Pain Disability Index (PDI). The model will be built with data gathered as part of routine practice. Expected outcome of the research: The deliverable will be a clinical predication model, which can be used in follow-up research.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 2309
Est. completion date December 31, 2023
Est. primary completion date January 17, 2022
Accepts healthy volunteers No
Gender All
Age group 16 Years and older
Eligibility Inclusion Criteria: - Chronic musculoskeletal pain > 3 months and osteoarthritis - Large personal and social dysfunction - Interplay of biological, social and psychological factors maintaining pain and/or disability Exclusion criteria: - Inability to actively participate in treatment (insufficient motivation, limited Dutch language skills, environmental factors, other pending treatments) - Disagreement between patient and care providers on content of treatment - Pending legal procedures that hinder full cooperation

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
interdisciplinary multimodal pain treatment
A combination of physical and psychosocial treatment methods is employed, including Emotional Awareness and Expression Therapy (EAET), Pain Neuroscience Education (PNE), Acceptance and Commitment Therapy (ACT), graded activity, exposure in vivo, and experiential learning through physical training.

Locations

Country Name City State
Netherlands Centrum voor Integrale Revalidatie Zwolle Overijssel

Sponsors (3)

Lead Sponsor Collaborator
Maastricht University Centrum voor Integrale Revalidatie (CIR), Pfizer

Country where clinical trial is conducted

Netherlands, 

References & Publications (1)

Breugelmans L, Scheffer E, Beckers LWME, Oosterwijk RFA, Nijland G, Smeets RJEM. Systematic description of an interdisciplinary multimodal pain treatment programme for patients with chronic musculoskeletal pain, using the TIDieR checklist. BMC Res Notes. 2022 Oct 11;15(1):320. doi: 10.1186/s13104-022-06211-z. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Other Brief Illness Perception Questionnaire Measures the cognitive and emotional representation of illness in a patient Baseline
Other Pain Self Efficacy Questionnaire Measures how confident the patient is that he/she will be able to perform daily tasks despite being in pain baseline
Other Psychological Inflexibility in Pain Scale Measures psychological inflexibility (avoidance of pain and cognitive fusion with pain) Baseline
Other Symptom Checklist 90 Measures to which degree the patient suffers from 90 different physical and psychological symptoms. Baseline
Other Hospital Anxiety and Depression Scale Measures feelings of fear and depression, without looking at physical complaints Baseline
Other General CIR questionnaire Records general socio-demographic characteristics as well as symptom-related information, co-morbidity and medication levels. baseline
Other Pain Catastrophising Scale Measures degree of catastrophizing Baseline
Other Checklist Individual Strength Measures subjective tiredness Baseline
Other Twelve-Item Short Form Health Survey Measures physical and mental functioning Baseline
Other Patient Specific Complaint Measures a patient's functional status by inquiring for three self-selected daily activities to which degree the patient is limited in this activity by his/her pain complaints Baseline
Primary Pain Disability Index Measures to which degree pain prevents the patient from participating in daily activities. Improvement equal or higher than Minimal Clinically Important Change (MCID; which is 9 points) is defined as successful treatment, and all others as not successful treatment Population will be dichotomized into successful or non-successful treatment and this will be the dependent variable for the logistic regression analysis used to build the prediction model baseline (start of treatment) and 10 weeks
See also
  Status Clinical Trial Phase
Completed NCT01659073 - Using Perfusion MRI to Measure the Dynamic Changes in Neural Activation Associated With Caloric Vestibular Stimulation N/A
Recruiting NCT05914311 - Use of Dermabond in Mitigation of Spinal Cord Stimulation (SCS) Trial Lead Migration N/A
Recruiting NCT05422456 - The Turkish Version of Functional Disability Inventory
Enrolling by invitation NCT05422443 - The Turkish Version of Pain Coping Questionnaire
Completed NCT05057988 - Virtual Empowered Relief for Chronic Pain N/A
Completed NCT04385030 - Neurostimulation and Mirror Therapy in Traumatic Brachial Plexus Injury N/A
Recruiting NCT06206252 - Can Medical Cannabis Affect Opioid Use?
Completed NCT05103319 - Simultaneous Application of Ketamine and Lidocaine During an Ambulatory Infusion Therapy as a Treatment Option in Refractory Chronic Pain Conditions
Completed NCT03687762 - Back on Track to Healthy Living Study N/A
Completed NCT04171336 - Animal-assisted Therapy for Children and Adolescents With Chronic Pain N/A
Completed NCT03179475 - Targin® for Chronic Pain Management in Patients With Spinal Cord Injury Phase 4
Completed NCT03418129 - Neuromodulatory Treatments for Pain Management in TBI N/A
Completed NCT03268551 - MEMO-Medical Marijuana and Opioids Study
Recruiting NCT06204627 - TDCS* and Laterality Trainnning in Patients With Chronic Neck Pain N/A
Recruiting NCT06060028 - The Power of Touch. Non-Invasive C-Tactile Stimulation for Chronic Osteoarthritis Pain N/A
Completed NCT05496205 - A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers Phase 1
Completed NCT00983385 - Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking Either WHO Step I or Step II Analgesics or no Regular Analgesics Phase 3
Recruiting NCT05118204 - Randomized Trial of Buprenorphine Microdose Inductions During Hospitalization Phase 4
Terminated NCT03538444 - Repetitive Transcranial Magnetic Stimulation for Opiate Use Disorder N/A
Not yet recruiting NCT05812703 - Biometrics and Self-reported Health Changes in Adults Receiving Behavioral Treatments for Chronic Pain